Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 11 studies | 26% ± 10% | |
peripheral blood | 8 studies | 23% ± 9% | |
brain | 7 studies | 32% ± 14% | |
intestine | 6 studies | 24% ± 10% | |
eye | 6 studies | 26% ± 9% | |
kidney | 5 studies | 18% ± 4% | |
liver | 4 studies | 32% ± 19% | |
pancreas | 3 studies | 39% ± 7% | |
uterus | 3 studies | 28% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 3971.06 | 459 / 459 | 100% | 33.51 | 1118 / 1118 |
esophagus | 100% | 3846.41 | 1445 / 1445 | 100% | 33.94 | 183 / 183 |
lung | 100% | 3913.05 | 578 / 578 | 100% | 34.21 | 1155 / 1155 |
ovary | 100% | 3921.31 | 180 / 180 | 100% | 22.71 | 430 / 430 |
uterus | 100% | 3994.16 | 170 / 170 | 100% | 32.83 | 459 / 459 |
brain | 100% | 3081.33 | 2637 / 2642 | 100% | 27.06 | 705 / 705 |
prostate | 100% | 3293.62 | 245 / 245 | 100% | 26.24 | 501 / 502 |
liver | 100% | 3138.35 | 226 / 226 | 100% | 20.09 | 405 / 406 |
bladder | 100% | 3653.00 | 21 / 21 | 100% | 29.31 | 502 / 504 |
kidney | 100% | 3305.35 | 89 / 89 | 99% | 20.71 | 896 / 901 |
thymus | 100% | 3919.91 | 653 / 653 | 99% | 28.35 | 601 / 605 |
pancreas | 100% | 2142.95 | 327 / 328 | 99% | 26.08 | 177 / 178 |
stomach | 100% | 3012.31 | 359 / 359 | 99% | 25.46 | 283 / 286 |
intestine | 100% | 3575.19 | 966 / 966 | 99% | 28.05 | 521 / 527 |
adrenal gland | 100% | 4053.97 | 258 / 258 | 98% | 22.93 | 225 / 230 |
skin | 100% | 3826.81 | 1808 / 1809 | 94% | 21.05 | 446 / 472 |
lymph node | 0% | 0 | 0 / 0 | 100% | 30.06 | 29 / 29 |
muscle | 100% | 5919.89 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 3994.55 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 30.57 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.97 | 1 / 1 |
blood vessel | 100% | 3996.89 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 3943.27 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 99% | 3297.97 | 849 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 81% | 13.12 | 65 / 80 |
peripheral blood | 75% | 1927.51 | 700 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1901800 | Biological process | positive regulation of proteasomal protein catabolic process |
GO_0045899 | Biological process | positive regulation of RNA polymerase II transcription preinitiation complex assembly |
GO_0090261 | Biological process | positive regulation of inclusion body assembly |
GO_0036503 | Biological process | ERAD pathway |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0000502 | Cellular component | proteasome complex |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016234 | Cellular component | inclusion body |
GO_0005829 | Cellular component | cytosol |
GO_0008540 | Cellular component | proteasome regulatory particle, base subcomplex |
GO_0031597 | Cellular component | cytosolic proteasome complex |
GO_0022624 | Cellular component | proteasome accessory complex |
GO_0005634 | Cellular component | nucleus |
GO_0042802 | Molecular function | identical protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0036402 | Molecular function | proteasome-activating activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PSMC6 |
Protein name | Proteasome 26S subunit, ATPase 6 26S proteasome regulatory subunit 10B (26S proteasome AAA-ATPase subunit RPT4) (Proteasome 26S subunit ATPase 6) (Proteasome subunit p42) |
Synonyms | SUG2 |
Description | FUNCTION: Component of the 26S proteasome, a multiprotein complex involved in the ATP-dependent degradation of ubiquitinated proteins. This complex plays a key role in the maintenance of protein homeostasis by removing misfolded or damaged proteins, which could impair cellular functions, and by removing proteins whose functions are no longer required. Therefore, the proteasome participates in numerous cellular processes, including cell cycle progression, apoptosis, or DNA damage repair. PSMC6 belongs to the heterohexameric ring of AAA (ATPases associated with diverse cellular activities) proteins that unfolds ubiquitinated target proteins that are concurrently translocated into a proteolytic chamber and degraded into peptides. . |
Accessions | ENST00000553798.5 A0A087X2I1 H0YJT1 H0YJX2 P62333 ENST00000612399.4 H0YJW2 H0YJE9 ENST00000555339.5 H0YJY8 H0YJS8 ENST00000556813.1 H0YJC0 ENST00000554044.5 ENST00000557517.1 ENST00000557240.5 ENST00000553899.5 ENST00000555175.1 ENST00000445930.7 H0YJD2 |